首页> 外文期刊>Biomaterials >Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.
【24h】

Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.

机译:聚磷酸酯微球,用于生物活性神经生长因子的持续释放。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Controlled delivery of neurotrophic proteins to a target tissue by biodegradable polymer microspheres has been explored widely for its potential applications in the treatment of various disorders in the nervous system. We investigated in this study the potential of polyphosphoester microspheres as carriers for the sustained release of nerve growth factor (NGF), a water-soluble neurotrophic protein. Two polyphosphoesters (PPEs), P(BHET-EOP/TC) and P(DAPG-EOP), as well as poly(lactide/glycolic acid) (PLGA), were used to fabricate microspheres by a W/O/W emulsion and solvent evaporation/extraction method. With bovine serum albumin as a model protein to optimize processing parameters. P(DAPG-EOP) microspheres exhibited a lower burst effect but similar protein entrapment levels and efficiencies when compared with those made of PLGA. Bioactive NGF could be released for at least 10 weeks from the P(DAPG-EOP) microspheres, as confirmed by a neurite outgrowth assay of the PC12 cells. These NGF containing microspheres were incorporated into the nerve guide conduits that were implanted to bridge a 10 mm gap in a rat sciatic nerve model. Two weeks after implantation, immunostaining with an antibody against the neurofilament protein confirmed the presence of axons at the distal end of regenerated cables within the NGF microsphere-loaded conduits. These results demonstrated the feasibility of using biodegradable PPEs for microencapsulation of NGF and provided a basis for future therapeutic application of the microspheres.
机译:由于可生物降解的聚合物微球控制的神经营养蛋白向靶组织的递送已被广泛研究,因为其在神经系统各种疾病的治疗中具有潜在的应用前景。在这项研究中,我们研究了多磷酸酯微球作为载体持续释放神经生长因子(NGF)(一种水溶性神经营养蛋白)的潜力。两种聚磷酸酯(PPE)P(BHET-EOP / TC)和P(DAPG-EOP)以及聚丙交酯/乙醇酸(PLGA)用于通过W / O / W乳液制备微球,溶剂蒸发/萃取法。以牛血清白蛋白为模型蛋白来优化加工参数。与PLGA制成的微球相比,P(DAPG-EOP)微球表现出较低的爆发效应,但蛋白质的包埋水平和效率相似。正如PC12细胞的神经突生长试验所证实的那样,具有生物活性的NGF可以从P(DAPG-EOP)微球中释放至少10周。将这些含有NGF的微球整合到神经导管中,该神经导管被植入以桥接大鼠坐骨神经模型中的10 mm间隙。植入后两周,用针对神经丝蛋白的抗体进行免疫染色,证实在NGF微球加载的导管内再生电缆的远端存在轴突。这些结果证明了使用可生物降解的PPE进行NGF微囊化的可行性,并为微球的未来治疗应用提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号